Ocugen Sets November 4 Earnings Report as Gene Therapy Advances
MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN) will report third-quarter 2026 financial results and provide a business update November 4, giving investors an opportunity to assess the Malvern-based biotechnology company’s …
Ocugen Sets November 4 Earnings Report as Gene Therapy Advances Read More